CD8A and neoplasm: Vaccination with HNRNPU or NCL enhanced dendritic cell activation, induced antigen-specific CD8+ T cell cytotoxicity, and promoted the formation of central memory CD8+ T cells, ultimately leading to CRC tumor reduction.